ATTO 8-K 2026-09-02

Attovia Therapeutics, Inc. (ATTO) 8-K dated 2026-09-02 — accession 0001193125-26-380215. This URL is the filing, not the ATTO hub.

Attovia Therapeutics, Inc. (ATTO) common stock.

Attovia Therapeutics, Inc. filed a 8-K on 2026-09-02. Accession 0001193125-26-380215.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ATTO revenue for 2026-06-30 was $450.0K. Net income was -$39.3M. ATTO currently screens at market cap $0.

Not investment advice. The ATTO SEC hub lists recent forms. The stock page is the research view.